Russell Investments Group
PRNB

Russell Investments Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Russell Investments Group’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,050
Closed -$1.32M – 3306
2020
Q2 		$1.32M Buy
22,050
+8,092
+58% +$500K ﹤0.01% 1890
2020
Q1 		$828K Sell
13,958
-53,391
-79% -$3.11M ﹤0.01% 1938
2019
Q4 		$3.69M Buy
67,349
+43,282
+180% +$1.62M 0.01% 1396
2019
Q3 		$680K Buy
24,067
+11,165
+87% +$410K ﹤0.01% 2183
2019
Q2 		$427K Buy
12,902
+5,982
+86% +$187K ﹤0.01% 2311
2019
Q1 		$235K Buy
+6,920
New +$220K ﹤0.01% 2573

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Russell Investments Group's PRNB Position: Q3 2020 in Review

Russell Investments Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 22,050 shares — an estimated $1.32M sold.

Russell Investments Group first reported a position in PRNB in Q1 2019 and held it in 6 quarters. The position peaked at $3.69M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Russell Investments Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Russell Investments Group sold 22,050 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.32M.
  • Russell Investments Group first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • Russell Investments Group's Principia Biopharma Inc. Common Stock position peaked at $3.69M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Russell Investments Group's 13F filing for Q3 2020, filed 9 Nov 2020.